South Koreans vote in historic election

May 9, 2017

Seoul, May 9: South Koreans went to the polls today to choose a new president after Park Geun-Hye was ousted and indicted for corruption, and against a backdrop of high tensions with the nuclear-armed North. Voters have been galvanised by anger over the sprawling bribery and abuse-of-power scandal that brought down Park, which catalysed frustrations over jobs and slowing growth.

Koreans

Left-leaning Moon Jae-In, a former human rights lawyer, has held a commanding lead in opinion polls for months, with the final Gallup Korea survey before a week-long pre-election blackout giving him 38 percent support, followed by former tech mogul Ahn Cheol-Soo on 20 per cent.

"I feel the people's strong will to change the government... We can make it a reality only when we vote", Moon said after casting his ballot with his wife at a polling station in western Seoul. Hong Joon-Pyo, of Park's Liberty Korea party, who languished in third place in the 13-strong field on 16 percent, urged voters to support him, branding Moon as a "pro-Pyongyang leftist".

Chung Tae-Wan, a 72-year-old doctor, cast his ballot at a polling station in the prosperous Seocho district of the capital. "I voted for Hong, as security (against North Korea) is the most important thing", he told AFP. Kim Kyung-Min, 24, said she cast her ballot in advance last week. "I was so disappointed in Park and the establishment", she told AFP, but refused to say whom she voted for.

More than 139,000 voting stations opened at 6 am local time (2100 GMT) across the country under overcast skies, with turnout expected to hit a record high. Exit poll results will be available immediately after voting closes at 8 pm (11:00 GMT).

The campaign has focused largely on the economy, with North Korea less prominent, but after a decade of conservative rule a Moon victory could mean a sea change in Seoul's approach towards both Pyongyang and key ally Washington.

The 64-year-old -- who is accused of being soft on the North by his critics -- has advocated dialogue to defuse tensions and to bring it to negotiations, and is seen to favour more independence in relations with the US, Seoul's security guarantor with 28,500 troops in the country.

Seoul needs to "take the lead on matters in the Korean peninsula" and South Koreans should not "take the back seat", he said in a recent media interview. The North has carried out two nuclear tests and a series of missile launches since the start of last year in its quest to develop a missile capable of delivering a nuclear warhead to the US mainland.

Washington has said military action was an option, sending fears of conflict spiralling. More recently US President Donald Trump has softened his message, saying he would be "honoured" to meet the North's leader, Kim Jong-Un.

Moon has also said he would be willing to visit Pyongyang to meet Kim and advocated resumption of some of the inter- Korea projects shuttered by his predecessors, including the Kaesong joint industrial zone. But for many South Korean voters, corruption, slowing growth, unemployment, and even air pollution from China top the list of concerns.

South Korea's rapid growth from the 1970s to 1990s pulled a war-ravaged nation out of poverty but slowed as the economy matured, and unemployment among under-30s is now at a record 10 per cent.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 14,2020

San Francisco, Mar 14: Microsoft on friday announced that co-founder Bill Gates has left its board of directors to devote more time to philanthropy.

The 64-year-old stopped being involved in day-to-day operations at the firm more than a decade ago, turning his attention to the foundation he launched with his wife, Melinda.

Gates served as chairman of Microsoft's board of directors until early in 2014 and has now stepped away entirely, according to the Redmond-based technology giant.

“It's been a tremendous honor and privilege to have worked with and learned from Bill over the years,” Microsoft chief executive and company veteran Satya Nadella said in a release.

Nadella said Microsoft would continue to benefit from Gates' “technical passion and advice” in his continuing role as a technical advisor.
“I am grateful for Bill's friendship and look forward to continuing to work alongside him,” he added.

Gates left his CEO position in 2000, handing the company reins to Steve Ballmer to devote more time to his charitable foundation.

He gave up the role of chairman at the same time Nadella became Microsoft's third CEO in 2014.

Regularly listed among the world's richest people, William H. Gates was a geeky-looking young man when he and Paul Allen co-founded Microsoft in 1975.

Gates went on to turn his attention from software to fighting disease and other humanitarian challenges with his wife, under the auspices of the Bill and Melinda Gates Foundation.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 20,2020

Wuhan, Jan 20: A 45-year-old Indian woman has become the first foreigner in China to have contracted a mysterious virus, which is suspected to be Severe Acute Respiratory Syndrome (SARS)-like corona virus.

In 2002-2003, the SARS corona virus killed around 650 people in China and Hong Kong. This time, a new strain of virus with 62 cases have been reported in Wuhan and two in Shenzhen so far. 19 patients have been already cured and discharged, as per the Chinese media.

Official sources in Beijing said that the patient, Preeti Maheshwari, a school teacher at an international school, is undergoing treatment for the new strain of pneumonia outbreak, which has been spreading in two major cities of China - Wuhan and Shenzen. She has been on a ventilator in the intensive care unit.

Maheshwari was admitted to a local hospital after she seriously fell ill last Friday. Her husband, a businessman from Delhi, is allowed to visit her daily.

Following a second death due to the outbreak of the virus in Wuhan, India on Friday issued an advisory to its nationals travelling to China. Over 500 Indian medical students are studying in Wuhan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.